# Propranolol for Early Secondary Prevention of Post-Traumatic Stress Disorder in Women Victims of Sexual Violence

> **NCT07452978** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University Hospital, Tours** · enrollment: 34 (estimated)

## Conditions studied

- PTSD - Post Traumatic Stress Disorder

## Interventions

- **DRUG:** Propranolol, 120mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07452978
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2027-10-06
- **Final completion:** 2028-03-01
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2026-03-05

## Collaborators

- Fondation Matmut Paul Bennetot

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07452978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07452978, "Propranolol for Early Secondary Prevention of Post-Traumatic Stress Disorder in Women Victims of Sexual Violence". Retrieved via AI Analytics 2026-08-20 from https://api.ai-analytics.org/clinical/NCT07452978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*